此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Resistance Exercise and Muscle Protein Synthesis in Obese Adults

2018年4月30日 更新者:University of Illinois at Urbana-Champaign

Resistance Exercise as a Strategy to Enhance Postprandial Muscle Protein Synthesis in Obese Adults

Obesity has numerous comorbidities that are associated with exceedingly high healthcare costs. In addition to well- characterized impairments in lipid and glucose metabolism, obesity is associated with altered protein metabolism. We have recently observed that obese individuals are essentially nonresponsive to protein ingestion with respect to myofibrillar protein synthesis. This suggests that skeletal muscle remodeling in obese individuals is impaired possibly contributing to a poor metabolic quality of muscle. Resistance exercise is known to strongly augment muscle protein synthesis in response to protein ingestion. The purpose of this research is to determine the muscle protein synthetic response during post-exercise recovery in obese individuals. Using stable isotope methodology, we will determine the postprandial muscle protein synthetic response in 14 male and female obese adults (Age: 20-45, BMI: 30-39.9 kg/m2) immediately after an acute bout of resistance exercise. Participants will be sedentary (< 60 min exercise/ week) and weight stable for a minimum of 6 months. During the testing blood and muscle samples will be collected. In addition participants will be asked to perform moderate intensity resistance exercise. Completion of the proposed research will identify the role of resistance exercise in the maintenance of skeletal muscle tissue after the consumption of a protein-dense meal in obese people.

研究概览

地位

完全的

条件

详细说明

Baseline procedures:

A parallel group design will be used for this study. Prior to the infusion trial, participants will reported to the laboratory on two separate occasions in the morning. On the first visit, we will determine participants' body weight and height as well as body composition by dual-energy X-ray absorptiometry. Finally, participants will be familiarized with unilateral leg extension and the ten repetition maximum (10RM) procedure. On a separate occasion, each subject will arrive to the lab after an overnight fast for the determination of oral glucose tolerance in response to the consumption of 75 g glucose dissolved in 500 mL of water. At the end of this visit, we will assess participant's unilateral 10RM for leg extension. In addition, participants will be instructed to refrain from vigorous physical activity and alcohol for three days prior to the tracer infusion.

Infusion protocol On the day of the infusion trial, participants will report to the laboratory at ~0700 h after a 10 h fast. An intravenous catheter will be inserted into an antecubital vein for baseline blood sample collection, after which a primed (2 μmol·kg-1), continuous infusion (0.05 μmol·kg Lean Body Mass-1·min-1) of L-[ring-13C6]phenylalanine will be initiated (t=-180 min) and maintained until the end of the trial. A second intravenous catheter placed in a contralateral dorsal hand vein will be placed in a heated blanket for repeated arterialized blood sampling. In the post-absorptive state, muscle biopsies of the vastus lateralis are to be collected at 0 min of infusion from a non-exercised control leg (CON). Subsequently, participants will perform moderate intensity unilateral leg extension exercise. Upon completion, participants will consume 170 g of lean ground pork (36 g protein). Additional muscle biopsies will be collected from both the exercised (EX) and CON legs at 120 and 300 min after pork ingestion. Arterialized blood samples will be collected every 30 or 60 min during the post-absorptive and postprandial-states and placed in pre-chilled EDTA tubes.

研究类型

介入性

注册 (实际的)

19

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Illinois
      • Urbana、Illinois、美国、61801
        • Freer Hall

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

20年 至 45年 (成人)

接受健康志愿者

是的

有资格学习的性别

全部

描述

  1. Inclusion criteria

    • Healthy-weight adults: BMI 18-24.9 kg/m2
    • Obese adults: BMI 30-39.9 kg/m2
    • Aged between 20-45 years
    • Healthy
    • Sedentary
  2. Exclusion criteria

    • Smoking
    • Allergies to pork consumption
    • Unusually high protein consumption
    • Vegetarians
    • Phenylketonuria (PKU)
    • Diagnosed GI tract diseases
    • Arthritic conditions
    • A history of neuromuscular problems
    • Previous participation in amino acid tracer studies
    • Predisposition to hypertrophic scarring or keloid formation
    • Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
    • Irregular menstrual cycles during the previous year
    • Pregnancy
    • High BMI that is not representative of being obese (e.g. resistance trained individuals, football players)
    • Contraindications for exercise

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:肥胖
Participants will perform 4 sets of 12 repetitions of moderate intensity leg extension
有源比较器:Normal Weight
Participants will perform 4 sets of 12 repetitions of moderate intensity leg extension

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Myofibrillar protein synthesis
大体时间:change over a 300 minute postprandial period
Fractional synthesis rate of myofibrillar proteins
change over a 300 minute postprandial period

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年1月1日

初级完成 (实际的)

2018年2月1日

研究完成 (实际的)

2018年5月1日

研究注册日期

首次提交

2017年12月12日

首先提交符合 QC 标准的

2018年1月19日

首次发布 (实际的)

2018年1月26日

研究记录更新

最后更新发布 (实际的)

2018年5月1日

上次提交的符合 QC 标准的更新

2018年4月30日

最后验证

2017年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • 16699

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅